204
Participants
Start Date
February 22, 2019
Primary Completion Date
January 31, 2029
Study Completion Date
January 31, 2029
Palliative Radiation
Investigators should follow the principles of palliative radiotherapy as per the individual institution in order to alleviate symptoms or prevent complications. If radiotherapy is indicated, recommended doses are 8 Gy in 1 fraction, 20 Gy in 5 fractions, and 30 Gy in 10 fractions.
Chemotherapy
Chemotherapy may be given as indicated.
Immunotherapy
Immunotherapy may be given as indicated.
Hormones
Hormones may be given as indicated.
Observation
Observation only is acceptable if this is the standard practice.
Stereotactic Ablative Radiotherapy
Total dose of radiation and number of fractions will depend on the site of disease. Doses are 20 Gy in 1 fraction, 30 Gy in 3 fractions (every 2 days), or 35 Gy in 5 fractions (daily).
Alfred Health, Melbourne
University Hospital of Zürich, Zurich
BC Cancer Agency, Vancouver Island Centre, Victoria
Nova Scotia Health Authortiy, Halifax
Health Sciences North, Greater Sudbury
Grand River Hospital, Kitchener
London Regional Cancer Program of the Lawson Health Research Institute, London
Trillium Health Partners-Credit Valley Hospital, Mississauga
Niagra Health System, St. Catharines
University Health Network, Toronto
Centre hospitalier de l'Université de Montréal-CHUM, Montreal
VU University Medical Centre, Amsterdam
Western General Hospital, Edinburgh
Beatson West of Scotland Cancer Centre, Glasgow
Collaborators (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
British Columbia Cancer - Centre for the North
UNKNOWN
Beaston West of Scotland Cancer Centre
UNKNOWN
London Health Sciences Centre
OTHER
David Palma
OTHER